15.02.2013 Views

world cancer report - iarc

world cancer report - iarc

world cancer report - iarc

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ing the optic tract, brain stem and spinal<br />

cord. It infiltrates adjacent brain structures<br />

but grows slowly and usually has a<br />

favourable prognosis with five-year survival<br />

rates of more than 85% (WHO Grade<br />

I). Some pilocytic astrocytomas occur in<br />

the setting of neurofibromatosis type 1<br />

(NF1), particularly those of the optic nerve<br />

(optic glioma). Other astrocytomas usually<br />

develop in the cerebral hemispheres of<br />

adults and diffusely infiltrate adjacent<br />

brain structures.<br />

Low grade diffuse astrocytomas (WHO<br />

grade II) occur in young adults and grow<br />

slowly. However, they diffusely infiltrate<br />

the brain and cannot, therefore, be completely<br />

surgically resected.<br />

Morphologically, tumour cells resemble<br />

differentiated astrocytes. Mutations in<br />

p53 are found in two-thirds of cases and<br />

are considered an early event. The fiveyear<br />

survival rate is more than 60%.<br />

Anaplastic astrocytomas (WHO grade III)<br />

often develop from low-grade astrocytomas,<br />

grow relatively fast and typically<br />

progress to glioblastoma within two to<br />

three years, accompanied by genetic alterations,<br />

including loss of heterozygosity<br />

(LOH) on chromosome 19.<br />

Glioblastomas (WHO grade IV)<br />

This is the most frequent and most malignant<br />

nervous system tumour. Secondary<br />

glioblastomas develop by malignant progression<br />

from low-grade and anaplastic<br />

astrocytoma and are characterized by p53<br />

mutations and LOH on chromosome 10q.<br />

Primary glioblastomas are more frequent<br />

(>80% of cases) and develop rapidly in the<br />

elderly (mean age, 55 years), with a short<br />

clinical history of less than three months.<br />

Their genetic profile includes amplification<br />

and overexpression of the EGF receptor<br />

gene, PTEN mutations, p16 INK4A deletions<br />

and loss of chromosome 10. Both glioblastoma<br />

types diffusely infiltrate the brain,<br />

including the opposite hemisphere and<br />

show high cellularity and large areas of<br />

necrosis despite excessive vascular proliferation.<br />

Oligodendrogliomas<br />

These neoplasms develop from myelinproducing<br />

oligodendroglial cells or their<br />

Fig. 5.151 An MRI scan of a primary glioblastoma in a 79 year-old patient. A small cortical lesion rapidly<br />

developed into a full-blown glioblastoma with perifocal oedema and central necrosis.<br />

precursors and are typically found in the<br />

cerebral hemispheres of adults, often<br />

including the basal ganglia. Histologically,<br />

they are isomorphic, with a typical honeycomb<br />

pattern and delicate tumour vessels<br />

(“chicken wire” pattern). Anaplastic<br />

oligodendrogliomas (WHO Grade III) show<br />

features of anaplasia and high mitotic<br />

activity and carry a less favourable prog-<br />

nosis. Genetic hallmarks of oligodendrogliomas<br />

are LOH on chromosomes 1p<br />

and 19q. Oligodendrogliomas that carry<br />

these genetic alterations show a remarkable<br />

sensitivity to chemotherapy.<br />

Ependymomas<br />

These gliomas develop from the ependymal<br />

lining of the cerebral ventricles and<br />

Differentiated astrocytes or precursor cells<br />

mutation (>65%)<br />

α<br />

overexpression ( ~ 60%)<br />

Low grade astrocytoma<br />

( ~ 50%)<br />

alteration ( ~ 25%)<br />

Anaplastic astrocytoma<br />

mutation (5%)<br />

loss of expression ( ~ 50%)<br />

α amplification (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!